Clinical Trial Update: The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor

View source ↗

Summary

A completed clinical trial study examining the experiences of parents, clinician researchers, and the industry sponsor in the Ataluren (PTC124) Duchenne Muscula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• PTC124 (Ataluren) (Ataluren)

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Duchenne Muscular Dystrophy | Status: COMPLETED